Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-089473

Options or other derivatives

  • Chief Financial Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Schoch Charles Chief Financial Officer 2025-06-20 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D
Loading xslF345X05/ownership.xml…